2019 ASCO Annual Meeting iPlanner | Point/Counterpoint: Duration of Therapy in Indolent Lymphoma and Chronic Lymphocytic Leukemia

2019 ASCO Annual Meeting iPlanner

Point/Counterpoint: Duration of Therapy in Indolent Lymphoma and Chronic Lymphocytic Leukemia

Tuesday, June 4, 8:00 AM - 9:15 AM

Mark J. Roschewski, MD, Senior Clinician of the Lymphoid Malignancies Branch in NCI's Center for Cancer Research will present on "No Maintenance Required: Arguing in Favor of Observation after Frontline Therapy in Follicular Lymphoma." This education session follows both Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia tracks.